Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Oncology|May 13, 2004
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt, Udo Bilkenroth, Clemens Linné, et al.
The Journal of Urology|May 6, 2004
Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cellsSusanne Fuessel, Bernd Kueppers, Shuangli Ning, et al.
Lancet (London, England)|March 29, 2002
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcomaPeter Würl, Matthias Kappler, Axel Meye, et al.
Urology|December 15, 2004
Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinomaOliver W Hakenberg, Susanne Fuessel, Katja Richter, et al.
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosisKaren Bluemke, Udo Bilkenroth, Axel Meye, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Cancer Letters|February 7, 2006
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel, Jana Herrmann, Shuangli Ning, et al.
Cancer Gene Therapy|January 24, 2004
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53Matthias Kappler, Matthias Bache, Frank Bartel, et al.
Pageof 6